T1	Outcomes 1431 1607	death within 60 days (primary outcome), survival, cardiovascular events, performance status, quality of life (QOL), symptoms, number of nonstatin medications, and cost savings.
T2	Outcomes 1753 1766	Mean (SD) age
T3	Outcomes 2093 2102	Total QOL
T4	Outcomes 2232 2253	cardiovascular events
T5	Outcomes 2321 2338	Mean cost savings
T6	Outcomes 2530 2630	improved QOL, use of fewer nonstatin medications, and a corresponding reduction in medication costs.
